Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Sales | 46,195 | 44,345 | 42,670 | 43,674 | 38,250 |
| Cost of Goods | 9,458 | 9,027 | 8,723 | 8,826 | 8,130 |
| Gross Profit | 36,737 | 35,318 | 33,947 | 34,848 | 30,120 |
| Operating Expenses | 32,601 | 33,947 | 35,977 | 31,542 | 27,332 |
| Operating Income | 4,594 | 1,398 | -1,307 | 4,132 | 2,918 |
| Other Income | 57 | 31 | -5 | 8 | 325 |
| Pre-tax Income | 4,651 | 1,429 | -1,312 | 4,140 | 3,243 |
| Income Tax | 258 | 370 | 411 | 398 | 559 |
| Net Income Continuous | 4,393 | 1,059 | -1,723 | 3,742 | 2,684 |
| Net Income | $4,393 | $1,059 | $-1,723 | $3,742 | $2,684 |
| EPS Basic Total Ops | 0.11 | 0.03 | -0.04 | 0.09 | 0.07 |
| EPS Basic Continuous Ops | 0.11 | 0.03 | -0.04 | 0.10 | 0.07 |
| EPS Diluted Total Ops | 0.11 | 0.03 | -0.04 | 0.09 | 0.07 |
| EPS Diluted Continuous Ops | 0.11 | 0.03 | -0.04 | 0.09 | 0.07 |
| EBITDA(a) | $5,135 | $2,068 | $-655 | $4,769 | $3,555 |